Busch Matthew C.

Busch Matthew C. is listed in filings as VP at Amgen Inc. This profile follows SEC Form 4 activity through May 11, 2026, including sale activity. Recent filings connect the profile to Amgen Inc (AMGN). The current snapshot covers public activity from Nov 6, 2024 to May 11, 2026. Reported amounts are shown as $13.6K to $978.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.